GMO Taiwan Fund

Class Other (GMOTX)
Scorecard
4 / 5 Stars
Lipper
4 3 1 3 1
Zacks Investment Research
---
Standard & Poor's
4 / 5 Stars
TheStreet.com
E+ (Sell)

U.S. News evaluated 26 China Region Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.

See all GMO funds

See full China Region rankings

See more fund rankings

Performance

The fund has returned 19.38 percent over the past year, 3.73 percent over the past three years, 13.84 percent over the past five years, and 8.16 percent over the past decade.

Trailing Returns Updated 06.30.2014
Year to date 14.0%
1 Year 19.4%
3 Years (Annualized) 3.7%
5 Years (Annualized) 13.8%
10 Years (Annualized) 8.2%

See more GMOTX performance

Summary

The investment seeks total return in excess of that of its benchmark, the MSCI Taiwan Index. The fund typically makes equity investments directly and indirectly (e.g., through underlying funds or derivatives) in companies doing business in, or otherwise tied economically to, Taiwan. It may invest in companies of any market capitalization. Under normal circumstances, the fund invests directly and indirectly at least 80% of assets in investments tied economically to Taiwan. It is non-diversified.

Fees

Fees are Above Average compared to funds in the same category.
GMO Taiwan Fund has an expense ratio of 1.35 percent.

See more GMOTX fees

Risk

Risk is Below Average compared to funds in the same category according to Morningstar.

See more GMOTX risk

China Region Funds

Highest Returns (10-year)

See More Funds